• Thursday, 29 October 2020 08:00
    SparingVision Strengthens Management Team
  • Wednesday, 21 October 2020 07:00
    SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer
  • Tuesday, 30 June 2020 08:00
    SparingVision Receives European Orphan Designation for its Drug Candidate SPVN06 Dedicated to Inherited Retinal Dystrophies
  • Tuesday, 03 December 2019 07:00
    SparingVision wins First Prize at EIT European Health Catapult competition
  • Thursday, 25 July 2019 08:00
    SparingVision to Present at the Ophthalmology Innovation Summit (OIS) in Chicago on July 25th, 2019 during the American Society of Retinal Specialists (ASRS) meeting
  • Friday, 05 July 2019 08:00
    SparingVision awarded at EIC Accelerator program (H2020 SME instrument Phase 2), securing funding of €2.5 million
  • Thursday, 04 July 2019 08:00
    SparingVision sélectionnée au programme européen EIC Accelerator (H2020 SME instrument Phase 2) pour un financement de 2,5 millions d’euros
  • Thursday, 25 April 2019 08:00
    SparingVision to present preclinical datas for Retinitis Pigmentosa’s treatment during Annual Congress of the Association for Research in Vision and Ophthalmology (ARVO)
  • Tuesday, 26 February 2019 07:00
    Journée Internationale des Maladies Rares
  • Tuesday, 05 February 2019 07:00
    SparingVision récompensée par le « Mercure des Entrepreneurs HEC 2019 » dans la catégorie « Création d’Entreprise »
  • Tuesday, 09 January 2018 07:00
    SparingVision sélectionnée pour une présentation publique au 10e Biotech Showcase™
  • Monday, 08 January 2018 07:00
    SparingVision to Participate in the 10th Annual Biotech Showcase in San Francisco,
  • Wednesday, 12 July 2017 08:00
    1 For Release: July 12, 2017 Contact: Rhea Farberman, Foundation Fighting Blindness 410-423-0635 SparingVision Wins Grand Prize of 2017 i-Lab Contest for New, Innovative French Companies